Our Company / Alfasigma at glance
Pharmaceuticals
with passion
Alfasigma is an international pharmaceutical company founded in Italy, operating in more than 100 countries worldwide (through direct branches, affiliates and subsidiaries), with approximately 4,000 employees and a turnover of approximately EUR 1.4 billion in 2023.
With more than 75 years of history, Alfasigma has a long track record in the research, development, production and distribution of innovative therapeutic indications. Its product portfolio spans specialty care, primary care and consumer care in five main areas: Gastroenterology, in which it is a leader, Vascular, Rheumatology, Metabolic, Nutraceuticals & Medical foods.
The historical headquarters are in Bologna, Italy, with an additional office in Milan, while there are 6 production sites: in Italy, in Pomezia (RM), Alanno (PE), Sermoneta (LT) and Trezzano Rosa (MI) and abroad in Tortosa, Spain and in Shreveport (Louisiana), United States. The Research & Development Centres are located in Italy: in Pomezia (RM) and in the Kilometro Rosso Science and Technology Park in Bergamo.
Geographic coverage
Subsidiaries
24 countries
Direct subsidiaries
Turnover
€ 1,367
millions in 2023
5 proprietary molecules
Rifaximin, Sulodexide, Carnitine, L-Methylfolate, Parnaparin
Contract Manufacturing – Business Unit
2
R&D Lab centers
6
Manufacturing plants
24
Countries with direct subsidiaries worldwide